InSightec's Convertible Note Round

InSightec raised a round of funding on February 26, 2012. Investors include GE Healthcare.

InSightec provides non-invasive therapy platforms, Exablate and Exablate Neuro, which are proven technology based on sound clinical evidence for treating essential tremor, painful bone metastases and …

Articles about InSightec's Convertible Note Round: